Search Results

Tier 3 Specialist Weight Management Service Operational SOP (S157)

The guidance defines what the patient journey through the Tier 3 Specialist Weight Management Service should look like, including: • How referrals are received • How referrals out of the service are completed (to Tier 2 and Tier 4 services) • Clinical thresholds and triage criteria • Patient flow and program content • Prescribing initiation and transition points • MDT roles and responsibilities • Discharge process It also aims to ensure equitable access, clinical safety and consistency in triage and discharge decisions across localities.

Disclosure Ref 2025255 - Guidelines and policies relating to translation and Interrupting services.doc

Freedom of information disclosure relating to guidelines and policies relating to translation and Interrupting services

Disclosure Ref 2025296 - Permanent medical (e.g., Consultant or Specialty Doctor level) Recruitment Data.doc

Freedom of information disclosure relating to details of unfilled permanent medical vacancies, the number of permanent medical appointments made in the past 12 months, and the contact details of the person responsible for permanent medical recruitment.

Disclosure Ref 2025325 - Myeloma patients & specific drugs used.doc

Freedom of information disclosure relating to myeloma patients and the use of specific drugs used for treatment

Your Health Records Leaflet - updated Jan 2019.pdf

Domestic Abuse and Sexual Violence Policy (P90)

To provide information about the practical help and support that is available to employees of DCHSFT who are currently experiencing domestic abuse, or are experiencing trauma as a result of their past experiences of abuse. This Policy also covers the approach to be taken where an employee’s behaviour towards their family may constitute domestic abuse. Providing this information empowers Managers to take effective, supportive action and reinforces the message that domestic abuse and sexual violence cannot be ignored.

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

L145 - Important advice for casts on lower limbs

Important advice for casts on lower limbs, patient information leaflet.

CoG - 11 March 2020 - updated.pdf

CoG Meeting Pack March 2020

Employee online user guide - temporary staffing.pdf